Search Results - "Sud, Amit"

Refine Results
  1. 1

    Epidemiology, genetics and treatment of multiple myeloma and precursor diseases by Hemminki, Kari, Försti, Asta, Houlston, Richard, Sud, Amit

    Published in International journal of cancer (15-12-2021)
    “…Multiple myeloma (MM) is a hematological malignancy caused by the clonal expansion of plasma cells. The incidence of MM worldwide is increasing with greater…”
    Get full text
    Journal Article
  2. 2

    Will polygenic risk scores for cancer ever be clinically useful? by Sud, Amit, Turnbull, Clare, Houlston, Richard

    Published in NPJ precision oncology (21-05-2021)
    “…Genome-wide association studies (GWAS) have identified associations between common genetic variants, single nucleotide polymorphisms (SNPs) and the risk of…”
    Get full text
    Journal Article
  3. 3

    Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk by Sud, Amit, Chattopadhyay, Subhayan, Thomsen, Hauke, Sundquist, Kristina, Sundquist, Jan, Houlston, Richard S., Hemminki, Kari

    Published in Blood (19-09-2019)
    “…Estimating familial cancer risks is clinically important in being able to discriminate between individuals in the population at differing risk for malignancy…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers by Went, Molly, Sud, Amit, Mills, Charlie, Hyde, Abi, Culliford, Richard, Law, Philip, Vijayakrishnan, Jayaram, Gockel, Ines, Maj, Carlo, Schumacher, Johannes, Palles, Claire, Kaiser, Martin, Houlston, Richard

    Published in Nature communications (25-03-2024)
    “…For many cancers there are only a few well-established risk factors. Here, we use summary data from genome-wide association studies (GWAS) in a Mendelian…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    T-cell Prolymphocytic Leukemia by Sud, Amit, MBChB, MRes, MRCP, Dearden, Claire, BSc, MBBS, MD, FRCP, FRCPath

    “…T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive T-cell malignancy. T-PLL can be distinguished from other lymphoid diseases by the evaluation…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Polygenic risk scores to stratify cancer screening should predict mortality not incidence by Vickers, Andrew J., Sud, Amit, Bernstein, Jonine, Houlston, Richard

    Published in NPJ precision oncology (30-05-2022)
    “…Population-based cancer screening programs such as mammography or colonscopy generally directed at all healthy individuals in a given age stratum. It has…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Genetic landscape of interval and screen detected breast cancer by Mills, Charlie, Sud, Amit, Everall, Andrew, Chubb, Daniel, Lawrence, Samuel E. D., Kinnersley, Ben, Cornish, Alex J., Bentham, Robert, Houlston, Richard S.

    Published in NPJ precision oncology (28-05-2024)
    “…Interval breast cancers (IBCs) are cancers diagnosed between screening episodes. Understanding the biological differences between IBCs and screen-detected…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The Primordial Growth Disorder 3-M Syndrome Connects Ubiquitination to the Cytoskeletal Adaptor OBSL1 by Hanson, Dan, Murray, Philip G., Sud, Amit, Temtamy, Samia A., Aglan, Mona, Superti-Furga, Andrea, Holder, Sue E., Urquhart, Jill, Hilton, Emma, Manson, Forbes D.C., Scambler, Peter, Black, Graeme C.M., Clayton, Peter E.

    Published in American journal of human genetics (12-06-2009)
    “…3-M syndrome is an autosomal-recessive primordial growth disorder characterized by significant intrauterine and postnatal growth restriction. Mutations in the…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20